Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 28643-80-3 Chemical Structure| 28643-80-3

Structure of Nigericin sodium salt
CAS No.: 28643-80-3

Chemical Structure| 28643-80-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nigericin sodium salt is an antibiotic obtained from Streptomyces hygroscopicus, acting as an H+, K+, and Pb2+ ion carrier and as an NLRP3 agonist.

Synonyms: Nigericin Sodium; Nigericin (sodium salt); NSC 292567

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nigericin sodium salt

CAS No. :28643-80-3
Formula : C40H67NaO11
M.W : 746.94
SMILES Code : C[C@H]1[C@](O[C@@H]2C[C@](CC[C@@H]3C)([H])O[C@@]3([H])[C@@H](C)C([O-])=O)([C@@H]([C@H](OC)C2)C)O[C@](C)([C@]4([H])O[C@](C)([C@]5([H])O[C@]([C@@]([C@H](C[C@H]6C)C)([H])O[C@@]6(O)CO)([H])C[C@@H]5C)CC4)C1.[Na+]
Synonyms :
Nigericin Sodium; Nigericin (sodium salt); NSC 292567
MDL No. :MFCD27977549
InChI Key :MOYOTUKECQMGHE-PDEFJWSRSA-M
Pubchem ID :16760591

Safety of Nigericin sodium salt

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H319-H335
Precautionary Statements:P261-P301+P310-P305+P351+P338
Class:6.1
UN#:3462
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages (BMDMs) 1 µM 1 hour To investigate whether DSS potentiates NLRP3 inflammasome activation. Results showed that DSS significantly enhanced nigericin-induced NLRP3 inflammasome activation. Cell Mol Immunol. 2022 Aug;19(8):925-943.
BACH1-deficient macrophages 20 μM 15 min To observe the activation of the NLRP3 inflammasome, results showed that in BACH1-deficient macrophages, nigericin treatment significantly increased the secretion of IL-1β and IL-18 after LPS stimulation. Redox Biol. 2022 May;51:102265.
N/TERT cells 5 µg/mL 3 h Nigericin inhibits protein synthesis through potassium efflux, leading to ribosome stalling and activation of ZAKα-dependent ribotoxic stress response (RSR). Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309579121.
primary keratinocytes 5 µg/mL 24 h Nigericin induces IL-1β secretion, and this process depends on NLRP1 and potassium efflux. Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309579121.
primary human skin, nasal, and corneal epithelial cells 6.7 µM 3 h Validate that nigericin activates the NLRP1 inflammasome, leading to pyroptosis, characterized by membrane swelling, GSDMD cleavage, ASC speck formation, rapid PI uptake, and IL-1 secretion. Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309579121.
BV2 cells 10 µM 45 min Nigericin was used to activate the NLRP3 inflammasome, promoting pyroptosis and the secretion of inflammatory cytokines in BV2 cells. The results showed that after Nigericin treatment, the protein expression of NLRP3, Caspase-1 P20, and GSDMD-N in BV2 cells significantly increased, and the mRNA levels of inflammatory factors IL-1β, TNF-α, and IL-6 also significantly increased. J Neuroinflammation. 2022 Sep 28;19(1):237.
Primary mouse microglia 10 µM 45 min Nigericin was used to activate the NLRP3 inflammasome, promoting microglial pyroptosis and the secretion of inflammatory cytokines. The results showed that after Nigericin treatment, the protein expression of NLRP3, Caspase-1 P20, and GSDMD-N in microglia significantly increased, and the secretion of inflammatory factors IL-1β, IL-18, TNF-α, and IL-6 also significantly increased. J Neuroinflammation. 2022 Sep 28;19(1):237.
THP-1 macrophages 5 μg/mL 60 min Induced pyroptosis, TFG-deficient THP-1 cells exhibited higher mitochondrial ROS production and pyroptotic cell death Cell Death Dis. 2022 Jan 28;13(1):93.
HL-1 cardiomyocytes 5 μM 1, 3, 6, 9, 12 h To investigate the subcellular localization changes of GSDMD-N under Nigericin-induced inflammatory stress, results showed a time-dependent translocation of GSDMD-N from mitochondria to cytoplasmic membrane. Clin Transl Med. 2022 Aug;12(8):e1002.
Mouse peritoneal macrophages (MPMs) 1 μM 12 h Activate NLRP3 inflammasomes to simulate an inflammatory environment and study the anti-inflammatory effects of hucMSC-derived exosomes. Results showed that hucMSC-derived exosomes significantly reduced NLRP3 inflammasome activation and IL-1β release. Stem Cell Res Ther. 2021 Jul 22;12(1):416.
THP-1 cells 1 μM 12 h Activate NLRP3 inflammasomes to simulate an inflammatory environment and study the anti-inflammatory effects of hucMSC-derived exosomes. Results showed that hucMSC-derived exosomes significantly reduced NLRP3 inflammasome activation and IL-1β release. Stem Cell Res Ther. 2021 Jul 22;12(1):416.
AML12 cells 20 mM 24 h To study the induction of PANoptosis by Nigericin under lipid stress. Results showed that Nigericin in combination with TNF-α and LPS significantly aggravated cell injury, as evidenced by decreased cell viability and increased LDH release. Acta Pharmacol Sin. 2023 May;44(5):1014-1028.
bone marrow-derived macrophages (BMDMs) 5 µM 1 hour Inhibited NLRP3 inflammasome activation, reduced release of caspase-1p10 and mature IL-1β. Acta Pharmacol Sin. 2023 Oct;44(10):2019-2036.
mouse macrophage cell line J774A.1 5 µM 1 hour Inhibited NLRP3 inflammasome activation, reduced release of caspase-1p10 and mature IL-1β. Acta Pharmacol Sin. 2023 Oct;44(10):2019-2036.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.34mL

0.27mL

0.13mL

6.69mL

1.34mL

0.67mL

13.39mL

2.68mL

1.34mL

References

 

Historical Records

Categories